Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines

  • Lee, Junghun; 
  • Kim, Hwan; 
  • Yu, Hana; 
  • Chung, Jae Yoon; 
  • Oh, Chang-Hyun; 
  • ... Hah, Jung-Mi; 
  • 외 2명
Citations

WEB OF SCIENCE

32
Citations

SCOPUS

35

초록

The synthesis of a novel series of pyrimidin-4-yl-1H-imidazol-2-yl derivatives 7, 8, 9 and their antiproliferative activities against A375P human melanoma cell line and WM3629 cell line were described. Most compounds showed superior antiproliferative activities compared to Sorafenib, the well-known RAF inhibitor. Among them, 7a exhibited potent activities on both cell lines (IC50 = 0.62 and 4.49 mu M, respectively) and turned out to be a selective and potent CRAF inhibitor. (C) 2010 Elsevier Ltd. All rights reserved.

키워드

Pyrimidin-4-yl-1H-imidazol-2-yl derivatives; Antiproliferative activity; Melanoma cell line; BRAF; CRAF; Selectivity; MALIGNANT-MELANOMA; BRAF; KINASE; INHIBITOR; MUTATIONS; CRAF; SORAFENIB; CANCER; RAF; ERK
제목
Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines
저자
Lee, Junghun; Kim, Hwan; Yu, Hana; Chung, Jae Yoon; Oh, Chang-Hyun; Yoo, Kyung Ho; Sim, Taebo; Hah, Jung-Mi
DOI
10.1016/j.bmcl.2010.01.064
발행일
2010-03
유형
Article
저널명
Bioorganic & Medicinal Chemistry Letters
권
20
호
5
페이지
1573 ~ 1577